cached image

Joseph J. Schildkraut - Publications

Affiliations: 
Harvard Medical School, Boston, MA, United States 
Area:
Biological psychiatry, catecholamines
Website:
http://www.news.harvard.edu/gazette/2008/10.23/11-mm.html

113 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Mooney JJ, Samson JA, McHale NL, Pappalarado KM, Alpert JE, Schildkraut JJ. Increased Gsα within blood cell membrane lipid microdomains in some depressive disorders: an exploratory study. Journal of Psychiatric Research. 47: 706-11. PMID 23490066 DOI: 10.1016/j.jpsychires.2013.02.005  1
2008 Mooney JJ, Samson JA, Hennen J, Pappalardo K, McHale N, Alpert J, Koutsos M, Schildkraut JJ. Enhanced norepinephrine output during long-term desipramine treatment: a possible role for the extraneuronal monoamine transporter (SLC22A3). Journal of Psychiatric Research. 42: 605-11. PMID 17727882 DOI: 10.1016/j.jpsychires.2007.07.009  1
2004 Green AI, Chau DT, Keung WM, Dawson R, Mesholam RI, Schildkraut JJ. Clozapine reduces alcohol drinking in Syrian golden hamsters. Psychiatry Research. 128: 9-20. PMID 15450910 DOI: 10.1016/j.psychres.2004.05.005  1
2004 Schildkraut JJ, Mooney JJ. Toward a rapidly acting antidepressant: the normetanephrine and extraneuronal monoamine transporter (uptake 2) hypothesis. The American Journal of Psychiatry. 161: 909-11. PMID 15121658 DOI: 10.1176/appi.ajp.161.5.909  1
2002 Canuso CM, Goldstein JM, Wojcik J, Dawson R, Brandman D, Klibanski A, Schildkraut JJ, Green AI. Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder. Psychiatry Research. 111: 11-20. PMID 12140115 DOI: 10.1016/S0165-1781(02)00123-3  1
1999 Green AI, Zimmet SV, Strous RD, Schildkraut JJ. Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine? Harvard Review of Psychiatry. 6: 287-96. PMID 10370435  1
1999 Posener JA, Schatzberg AF, Williams GH, Samson JA, McHale NL, Bessette MP, Schildkraut JJ. Hypothalamic-pituitary-adrenal axis effects on plasma homovanillic acid in man. Biological Psychiatry. 45: 222-8. PMID 9951570 DOI: 10.1016/S0006-3223(97)00550-7  1
1998 Posener JA, Schildkraut JJ, Williams GH, Schatzberg AF. Late feedback effects of hypothalamic-pituitary-adrenal axis hormones in healthy subjects. Psychoneuroendocrinology. 23: 371-83. PMID 9695137 DOI: 10.1016/S0306-4530(98)00006-7  1
1998 Mooney JJ, Samson JA, McHale NL, Colodzin R, Alpert J, Koutsos M, Schildkraut JJ. Signal transduction by platelet adenylate cyclase: alterations in depressed patients may reflect impairment in the coordinated integration of cellular signals (coincidence detection). Biological Psychiatry. 43: 574-83. PMID 9564442 DOI: 10.1016/S0006-3223(97)00327-2  1
1997 Posener JA, Schildkraut JJ, Williams GH, Schatzberg AF. Cortisol feedback effects on plasma corticotropin levels in healthy subjects. Psychoneuroendocrinology. 22: 169-76. PMID 9203227 DOI: 10.1016/S0306-4530(96)00046-7  1
1996 Vasile RG, Schwartz RB, Garada B, Holman BL, Alpert M, Davidson PB, Schildkraut JJ. Focal cerebral perfusion defects demonstrated by 99mTc-hexamethylpropyleneamine oxime SPECT in elderly depressed patients. Psychiatry Research. 67: 59-70. PMID 8797243 DOI: 10.1016/0925-4927(96)02689-3  1
1996 Posener JA, Schildkraut JJ, Samson JA, Schatzberg AF. Diurnal variation of plasma cortisol and homovanillic acid in healthy subjects. Psychoneuroendocrinology. 21: 33-8. PMID 8778902 DOI: 10.1016/0306-4530(95)00033-X  1
1995 Green AI, Schildkraut JJ. Should clozapine be a first-line treatment for schizophrenia? The rationale for a double-blind clinical trial in first-episode patients. Harvard Review of Psychiatry. 3: 1-9. PMID 9384923 DOI: 10.3109/10673229509017159  1
1995 Schildkraut JJ. The catecholamine hypothesis of affective disorders: a review of supporting evidence. 1965. The Journal of Neuropsychiatry and Clinical Neurosciences. 7: 524-33; discussion 5. PMID 8555758  1
1995 Samson JA, Gurrera RJ, Nisenson L, Schildkraut JJ. Platelet monoamine oxidase activity and deficit syndrome schizophrenia. Psychiatry Research. 56: 25-31. PMID 7792339 DOI: 10.1016/0165-1781(94)02555-W  1
1995 Rothenberg A, Milman DH, Corwin D, Schildkraut JJ, Hirshfeld AJ, Murphy JM. Creativity and mental illness [11 American Journal of Psychiatry. 152: 815-817. PMID 7726334  1
1995 Schildkraut JJ, Kopin IJ, Schanberg SM, Durell J. Norepinephrine metabolism and psychoactive drugs in the endogenous depressions. 1968. Pharmacopsychiatry. 28: 24-37. PMID 7480108 DOI: 10.1055/s-2007-979616  1
1995 Schildkraut JJ, Hirshfeld AJ. Mind and Mood in Modern Art I: Miró and “Melancolie” Creativity Research Journal. 8: 139-156. DOI: 10.1207/s15326934crj0802_3  1
1995 Posener JA, Schildkraut JJ, Williams GH, Gleason RE, Salomon MS, Schatzberg AF. Acute and delayed effects of adrenocorticotropic hormone on dopamine activity in man Depression. 2: 292-296.  1
1995 Neylan TC, Schildkraut JJ. Pathophysiology of affective disorders: Joseph J. Schildkraut's catecholamine hypothesis Journal of Neuropsychiatry and Clinical Neurosciences. 7: 523-533.  1
1994 Schildkraut JJ, Hirshfeld AJ, Murphy JM. Mind and mood in modern art, II: Depressive disorders, spirituality, and early deaths in the abstract expressionist artists of the New York School. The American Journal of Psychiatry. 151: 482-8. PMID 8147444  1
1994 Samson JA, Mirin SM, Griffin M, Borrelli D, Schildkraut JJ. Urinary MHPG and clinical symptoms in patients with unipolar depression. Psychiatry Research. 51: 157-65. PMID 8022950 DOI: 10.1016/0165-1781(94)90035-3  1
1994 Posener JA, Schildkraut JJ, Williams GH, Gleason RE, Salomon MS, Mecheri G, Schatzberg AF. Acute and delayed effects of corticotropin-releasing hormone on dopamine activity in man. Biological Psychiatry. 36: 616-21. PMID 7833428 DOI: 10.1016/0006-3223(94)90074-4  1
1993 Green AI, Alam MY, Sobieraj JT, Pappalardo KM, Waternaux C, Salzman C, Schatzberg AF, Schildkraut JJ. Clozapine response and plasma catecholamines and their metabolites. Psychiatry Research. 46: 139-49. PMID 8483973 DOI: 10.1016/0165-1781(93)90016-A  1
1993 Green AI, Alam MY, Boshes RA, Waternaux C, Pappalardo KM, Fitzgibbon ME, Tsuang MT, Schildkraut JJ. Haloperidol response and plasma catecholamines and their metabolites. Schizophrenia Research. 10: 33-7. PMID 8369230 DOI: 10.1016/0920-9964(93)90074-S  1
1993 Rothschild AJ, Samson JA, Bond TC, Luciana MM, Schildkraut JJ, Schatzberg AF. Hypothalamic-pituitary-adrenal axis activity and 1-year outcome in depression. Biological Psychiatry. 34: 392-400. PMID 8218607 DOI: 10.1016/0006-3223(93)90184-F  1
1992 Samson JA, Mirin SM, Hauser ST, Fenton BT, Schildkraut JJ. Learned helplessness and urinary MHPG levels in unipolar depression. The American Journal of Psychiatry. 149: 806-9. PMID 1590498  1
1992 Vasile RG, Duffy FH, McAnulty G, Mooney JJ, Bloomingdale K, Schildkraut JJ. Abnormal flash visual evoked response in melancholia: a replication study. Biological Psychiatry. 31: 325-36. PMID 1558897 DOI: 10.1016/0006-3223(92)90226-P  1
1992 Schildkraut JJ, Schatzberg AF, Samson JA, Rosenbaum A, Bowden CL. Norepinephrine output and metabolism in depressed patients during antidepressant treatments. Clinical Neuropharmacology. 15: 323A-324A. PMID 1498855  1
1992 Anderson JL, Vasile RG, Mooney JJ, Bloomingdale KL, Samson JA, Schildkraut JJ. Changes in norepinephrine output following light therapy for fall/winter seasonal depression. Biological Psychiatry. 32: 700-4. PMID 1457625 DOI: 10.1016/0006-3223(92)90299-F  1
1991 Mooney JJ, Schatzberg AF, Cole JO, Samson JA, Waternaux C, Gerson B, Pappalardo KM, Schildkraut JJ. Urinary 3-methoxy-4-hydroxyphenylglycol and the depression-type score as predictors of differential responses to antidepressants. Journal of Clinical Psychopharmacology. 11: 339-43. PMID 1770151  1
1990 Schildkraut JJ, Mooney JJ, Jacobs SC, Friedman R, McHale N, Benson H. Enhanced signal transduction by adenylate cyclase following elicitation of the relaxation response: Preliminary findings Journal of Psychiatric Research. 24: 55-56. DOI: 10.1016/0022-3956(90)90084-4  1
1989 Vasile RG, Duffy FH, McAnulty G, Bear D, Mooney JJ, Bloomingdale K, Serchuck LK, Schildkraut JJ. Abnormal visual evoked response in melancholia. Biological Psychiatry. 25: 785-8. PMID 2923938 DOI: 10.1016/0006-3223(89)90250-3  1
1989 Schatzberg AF, Samson JA, Bloomingdale KL, Orsulak PJ, Gerson B, Kizuka PP, Cole JO, Schildkraut JJ. Toward a biochemical classification of depressive disorders. X. Urinary catecholamines, their metabolites, and D-type scores in subgroups of depressive disorders. Archives of General Psychiatry. 46: 260-8. PMID 2783211 DOI: 10.1001/archpsyc.1989.01810030066009  1
1988 Minden SL, Orav J, Schildkraut JJ. Hypomanic reactions to ACTH and prednisone treatment for multiple sclerosis. Neurology. 38: 1631-4. PMID 2843795  1
1988 Mooney JJ, Schatzberg AF, Cole JO, Kizuka PP, Salomon M, Lerbinger J, Pappalardo KM, Gerson B, Schildkraut JJ. Rapid antidepressant response to alprazolam in depressed patients with high catecholamine output and heterologous desensitization of platelet adenylate cyclase. Biological Psychiatry. 23: 543-59. PMID 2833319 DOI: 10.1016/0006-3223(88)90002-9  1
1987 Schatzberg AF, Rothschild AJ, Langlais PJ, Lerbinger JE, Schildkraut JJ, Cole JO. Psychotic and nonpsychotic depressions: II. Platelet MAO activity, plasma catecholamines, cortisol, and specific symptoms. Psychiatry Research. 20: 155-64. PMID 3575560 DOI: 10.1016/0165-1781(87)90007-2  1
1987 Glassman AH, Arana GW, Baldessarini RJ, Brown WA, Carroll BJ, Davis JM, Greenblatt DJ, Klerman GL, Orsulak P, Schildkraut JJ, Shader RI. The dexamethasone suppression test: An overview of its current status in psychiatry American Journal of Psychiatry. 144: 1253-1262. PMID 3310667  1
1986 Bloomingdale KL, Vasile RG, Gudeman JE, Gerson B, Schildkraut JJ. The dexamethasone suppression test (DST) and platelet monoamine oxidase (MAO) activity as predictors of psychosis in depression. Biological Psychiatry. 21: 390-3. PMID 3955113 DOI: 10.1016/0006-3223(86)90167-8  1
1986 Biederman J, Baldessarini RJ, Harmatz JS, Rivinus TM, Arana GW, Herzog DB, Schildkraut JJ. Heterogeneity in anorexia nervosa. Biological Psychiatry. 21: 213-6. PMID 3004610 DOI: 10.1016/0006-3223(86)90149-6  1
1985 Samson JA, Gudeman JE, Schatzberg AF, Kizuka PP, Orsulak PJ, Cole JO, Schildkraut JJ. Toward a biochemical classification of depressive disorders--VIII. Platelet monoamine oxidase activity in subtypes of depressions. Journal of Psychiatric Research. 19: 547-55. PMID 4078757 DOI: 10.1016/0022-3956(85)90072-X  1
1985 Schatzberg AF, Rothschild AJ, Gerson B, Lerbinger JE, Schildkraut JJ. Toward a biochemical classification of depressive disorders IX. DST results and platelet MAO activity. The British Journal of Psychiatry : the Journal of Mental Science. 146: 633-7. PMID 4016477  1
1985 Biederman J, Herzog DB, Rivinus TM, Harper GP, Ferber RA, Rosenbaum JF, Harmatz JS, Tondorf R, Orsulak PJ, Schildkraut JJ. Amitriptyline in the treatment of anorexia nervosa: a double-blind, placebo-controlled study. Journal of Clinical Psychopharmacology. 5: 10-6. PMID 3973067  1
1985 Mooney JJ, Schatzberg AF, Cole JO, Kizuka PP, Schildkraut JJ. Enhanced signal transduction by adenylate cyclase in platelet membranes of patients showing antidepressant responses to alprazolam: preliminary data. Journal of Psychiatric Research. 19: 65-75. PMID 2985777 DOI: 10.1016/0022-3956(85)90069-X  1
1985 Mooney JJ, Cole JO, Schatzberg AF, Gerson B, Schildkraut JJ. Pretreatment urinary MHPG levels as predictors of antidepressant responses to alprazolam. The American Journal of Psychiatry. 142: 366-7. PMID 2857533  1
1984 Biederman J, Herzog DB, Rivinus TM, Ferber RA, Harper GP, Orsulak PJ, Harmatz JS, Schildkraut JJ. Urinary mhpg in anorexia nervosa patients with and without a concomitant major depressive disorder. Journal of Psychiatric Research. 18: 149-60. PMID 6747913 DOI: 10.1016/0022-3956(84)90006-2  1
1984 Biederman J, Rivinus TM, Herzog DB, Ferber RA, Harper GP, Orsulak PJ, Harmatz JS, Schildkraut JJ. Platelet MAO activity in anorexia nervosa patients with and without a major depressive disorder. The American Journal of Psychiatry. 141: 1244-7. PMID 6486260  1
1984 Sheehan DV, Coleman JH, Greenblatt DJ, Jones KJ, Levine PH, Orsulak PJ, Peterson M, Schildkraut JJ, Uzogara E, Watkins D. Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment. Journal of Clinical Psychopharmacology. 4: 66-75. PMID 6142907  1
1983 Rosenbaum AH, Maruta T, Schatzberg AF, Orsulak PJ, Jiang NS, Cole JO, Schildkraut JJ. Toward a biochemical classification of depressive disorders, VII: urinary free cortisol and urinary MHPG in depressions. The American Journal of Psychiatry. 140: 314-8. PMID 6829802  1
1983 Orsulak PJ, Kizuka P, Grab E, Schildkraut JJ. Determination of urinary normetanephrine and metanephrine by radial-compression liquid chromatography and electrochemical detection. Clinical Chemistry. 29: 305-9. PMID 6821934  1
1983 Schatzberg AF, Orsulak PJ, Rothschild AJ, Salomon MS, Lerbinger J, Kizuka PP, Cole JO, Schildkraut JJ. Platelet MAO activity and the dexamethasone suppression test in depressed patients. The American Journal of Psychiatry. 140: 1231-3. PMID 6614239  1
1982 Schildkraut JJ. The biochemical discrimination of subtypes of depressive disorders: an outline of our studies on norepinephrine metabolism and psychoactive drugs in the endogenous depressions since 1967. Pharmacopsychiatria. 15: 121-7. PMID 7146090 DOI: 10.1055/s-2007-1019523  1
1982 Gudeman JE, Schatzberg AF, Samson JA, Orsulak PJ, Cole JO, Schildkraut JJ. Toward a biochemical classification of depressive disorders, VI: Platelet MAO activity and clinical symptoms in depressed patients. The American Journal of Psychiatry. 139: 630-3. PMID 7072851  1
1982 Schatzberg AF, Orsulak PJ, Rosenbaum AH, Maruta T, Kruger ER, Cole JO, Schildkraut JJ. Toward a biochemical classification of depressive disorders, V: Heterogeneity of unipolar depressions. The American Journal of Psychiatry. 139: 471-5. PMID 7065292  1
1982 Mooney JJ, Horne WC, Handin RI, Schildkraut JJ, Alexander RW. Sodium inhibits both adenylate cyclase and high-affinity 3H-labeled p-aminoclonidine binding to alpha 2-adrenergic receptors in purified human platelet membranes. Molecular Pharmacology. 21: 600-8. PMID 6287197  1
1981 Mooney JJ, Chao FC, Orsulak PJ, Adler SA, Schildkraut JJ. Platelet monoamine oxidase activity in psychiatric disorders: the application of a technique for the isolation of free platelet mitochondria from relatively small blood samples. Journal of Psychiatric Research. 16: 163-71. PMID 7346628 DOI: 10.1016/0022-3956(81)90002-9  1
1981 Mooney JJ, Chao FC, Orsulak PJ, Schildkraut JJ. An improved method for the recovery of mitochondrial monoamine oxidase from human platelets using colchicine and nitrogen decompression. Biochemical Medicine. 26: 156-66. PMID 7317037 DOI: 10.1016/0006-2944(81)90042-9  1
1981 Schildkraut JJ, Orsulak PJ, Schatzberg AF, Cole JO, Rosenbaum AH. Possible pathophysiological mechanisms in subtypes of unipolar depressive disorders based on differences in urinary MHPG levels [proceedings]. Psychopharmacology Bulletin. 17: 90-91. PMID 7232668  1
1981 Cassens G, Kuruc A, Roffman M, Orsulak PJ, Schildkraut JJ. Alterations in brain norepinephrine metabolism and behavior induced by environmental stimuli previously paired with inescapable shock. Behavioural Brain Research. 2: 387-407. PMID 7225224 DOI: 10.1016/0166-4328(81)90020-6  1
1981 Schatzberg AF, Rosenbaum AH, Orsulak PJ, Rohde WA, Maruta T, Kruger ER, Cole JO, Schildkraut JJ. Toward a biochemical classification of depressive disorders. III: Pretreatment urinary MHPG levels as predictors of response to treatment with maprotiline. Psychopharmacology. 75: 34-8. PMID 6795656 DOI: 10.1007/BF00431641  1
1981 Cassens G, Actor C, Kling M, Schildkraut JJ. Amphetamine withdrawal: effects on threshold of intracranial reinforcement. Psychopharmacology. 73: 318-22. PMID 6789351  1
1981 Schatzberg AF, Rosenbaum AH, Orsulak PJ, Rohde WA, Maruta T, Kruger ER, Cole JO, Schildkraut JJ. Toward a biochemical classification of depressive disorders - III: Pretreatment urinary MHPG levels as predictors of response to treatment with maprotiline Psychopharmacology. 75: 34-38. DOI: 10.1007/BF00433498  1
1980 Schatzberg AF, Orsulak PJ, Rosenbaum AH, Kruger ER, Schildkraut JJ, Cole JO. Catecholamine measures for diagnosis and treatment of patients with depressive disorders. The Journal of Clinical Psychiatry. 41: 35-9. PMID 7440524  1
1980 Rosenbaum AH, Schatzberg AF, Maruta T, Orsulak PJ, Cole JO, Grab EL, Schildkraut JJ. MHPG as a predictor of antidepressant response to imipramine and maprotiline. The American Journal of Psychiatry. 137: 1090-2. PMID 7425162  1
1980 Cassens G, Roffman M, Kuruc A, Orsulak PJ, Schildkraut JJ. Alterations in brain norepinephrine metabolism induced by environmental stimuli previously paired with inescapable shock. Science (New York, N.Y.). 209: 1138-40. PMID 7403874 DOI: 10.1126/science.7403874  1
1980 Adler SA, Gottesman II, Orsulak PJ, Kizuka PP, Schildkraut JJ. Platelet MAO activity: relationships to clinical and psychometric variables. Schizophrenia Bulletin. 6: 226-31. PMID 7375854 DOI: 10.1093/schbul/6.2.226  1
1980 Schildkraut JJ, Orsulak PJ, Schatzberg AF, Herzog JM. Platelet monoamine oxidase activity in subgroups of schizophrenic disorders. Schizophrenia Bulletin. 6: 220-5. PMID 7375853  1
1980 Schatzberg AF, Orsulak PJ, Rosenbaum AH, Maruta T, Kruger ER, Cole JO, Schildkraut JJ. Toward a biochemical classification of depressive disorders IV: Pretreatment urinary MHPG levels as predictors of antidepressant response to imipramine. Communications in Psychopharmacology. 4: 441-5. PMID 7333096  1
1980 Reigle TG, Orsulak PJ, Avni J, Platz PA, Schildkraut JJ. The effects of tranylcypromine isomers on norepinephrine-H3 metabolism in rat brain. Psychopharmacology. 69: 193-9. PMID 6779313 DOI: 10.1007/BF00427649  1
1979 Cassens G, Kuruc A, Orsulak PJ, Schildkraut JJ. Amphetamine withdrawal: effects on brain levels of MHPG-SO4 in the rat. Communications in Psychopharmacology. 3: 217-23. PMID 575083  1
1979 Appelbaum PS, Vasile RG, Orsulak PJ, Schildkraut JJ. Clinical utility of tricyclic antidepressant blood levels: a case report. The American Journal of Psychiatry. 136: 339-41. PMID 570360  1
1979 Orsulak PJ, Schildkraut JJ. Guidelines for therapeutic monitoring of tricyclic antidepressant plasma levels. Therapeutic Drug Monitoring. 1: 199-208. PMID 555572  1
1979 Roffman M, Reigle T, Orsulak P, Cassens G, Schildkraut JJ. Further studies of the effects of morphine on the levels of MHPG-SO4 in rat brain. Neuropharmacology. 18: 483-7. PMID 460544 DOI: 10.1016/0028-3908(79)90074-1  1
1978 Orsulak PJ, Schildkraut JJ, Schatzberg AF, Herzog JM. Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders. Biological Psychiatry. 13: 637-47. PMID 737252  1
1978 Schildkraut JJ, Orsulak PJ, LaBrie RA, Schatzberg AF, Gudeman JE, Cole JO, Rohde WA. Toward a biochemical classification of depressive disorders. II. Application of multivariate discriminant function analysis to data on urinary catecholamines and metabolites. Archives of General Psychiatry. 35: 1436-9. PMID 727879 DOI: 10.1001/archpsyc.1978.01770360040004  1
1978 Schildkraut JJ, Orsulak PJ, Schatzberg AF, Gudeman JE, Cole JO, Rohde WA, LaBrie RA. Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions. Archives of General Psychiatry. 35: 1427-33. PMID 727878 DOI: 10.1001/archpsyc.1978.01770360031003  1
1978 Roffman M, Cassens G, Schildkraut JJ. Effects of the d- and l-isomers of amphetamine on the levels of 3-methoxy-4-hydroxyphenylglycol sulfate in whole rat brain and rat brain regions. Biochemical Pharmacology. 27: 1774-7. PMID 708459 DOI: 10.1016/0006-2952(78)90556-7  1
1978 Schildkraut JJ, Orsulak PJ, Schatzberg AF, Cole JO, Gudeman JE, Rohde WA. Elevated platelet MAO activity in schizophrenia-related depressive disorders. The American Journal of Psychiatry. 135: 110-2. PMID 618506  1
1978 Meyer RE, Schildkraut JJ, Mirin SM, Orsulak PJ, Randall M, McDougle M, Platz PA, Grab E, Babor T. Opiates, catecholamines, behavior, and mood. Psychopharmacology. 56: 327-33. PMID 418442 DOI: 10.1007/BF00432857  1
1977 Schildkraut JJ, Meyer RE, Orsulak PJ, Mirin SM, Roffman M, Platz PA, Grab E, Randall ME, McDougle M. Catecholamine metabolism during heroin use. The American Journal of Psychiatry. 134: 534-7. PMID 848581  1
1977 Roffman M, Kling MA, Cassens G, Orsulak PJ, Reigle TG, Schildkraut JJ. The effects of acute and chronic administration of tricyclic antidepressants on MHPG-SO4 in rat brain. Communications in Psychopharmacology. 1: 195-206. PMID 606473  1
1977 Roffman M, Cassens G, Schildkraut JJ. The effects of acute and chronic administration of morphine on norepinephrine turnover in rat brain regions. Biochemical Pharmacology. 26: 2355-8. PMID 597324 DOI: 10.1016/0006-2952(77)90440-3  1
1976 Schildkraut JJ, Herzog JM, Orsulak PJ, Edelman SE, Shein HM, Frazier SH. Reduced platelet monoamine oxidase activity in a subgroup of schizophrenic patients. The American Journal of Psychiatry. 133: 438-40. PMID 1267046  1
1976 Schildkraut JJ, Roffman M, Orsulak PJ, Schatzberg AF, Kling MA, Reigle TG. Effects of short-and long-term administration of tricyclic antidepressants and lithium on norepinephrine turnover in brain. Pharmakopsychiatrie, Neuro-Psychopharmakologie. 9: 193-202. PMID 981331 DOI: 10.1055/s-0028-1094493  1
1976 Roffman M, Reigle TG, Orsulak PJ, Schildkraut JJ. Properties of catechol-O-methyl transferase in soluble and particulate preparations from rat red blood cells. Biochemical Pharmacology. 25: 208-9. PMID 4077 DOI: 10.1016/0006-2952(76)90294-X  1
1976 Roffman M, Cassens G, Kling M, Schildkraut JJ. Effects of drugs of addiction on the levels of MHPG SO4 in whole rat brain and various brain regions Federation Proceedings. 35: No.1460.  1
1975 Schildkraut JJ, Meyer RE, Orsulak PJ, Mirin SM, Roffman M, Platz PA, Grab E, Randall ME, McDougle M. The effects of heroin on catecholamine metabolism in man. National Institute On Drug Abuse Research Monograph Series. 137-45. PMID 1233382  1
1975 Avni J, Gerson S, Draskoczy PR, Schildkraut JJ. Norepinephrine content of various rat organs after chronic administration of desmethylimipramine. Archives Internationales De Pharmacodynamie Et De ThéRapie. 218: 106-9. PMID 1212010  1
1975 Schildkraut JJ. Norepinephrine metabolism after short- and long-term administration of tricyclic antidepressant drugs and electroconvulsive shock. Advances in Biochemical Psychopharmacology. 13: 137-53. PMID 1155232  1
1975 Schildkraut JJ. Catecholamines in affective disorders. Psychopharmacology Bulletin. 11: 35. PMID 1153657  1
1975 Roffman M, Reigle T, Orsulak P, Schildkraut JJ. The effects of acute and chronic morphine administration on the levels of 3-methoxy-4-hydroxphenylglycol sulfate in rat brain. Research Communications in Chemical Pathology and Pharmacology. 10: 403-17. PMID 1135507  1
1975 Schildkraut JJ. Psychopharmacology of biogenic amines in depressions. Psychopharmacology Bulletin. 11: 58-9. PMID 1135382  1
1975 Roffman M, Orsulak PJ, Schildkraut JJ. Further studies on the effects of drugs of addiction on the turnover of norepinephrine (NE) in rat brain Federation Proceedings. 34: No. 3217.  1
1974 Schildkraut JJ. The effects of lithium on norepinephrine turnover and metabolism: basic and clinical studies. The Journal of Nervous and Mental Disease. 158: 348-60. PMID 4823935  1
1974 Schildkraut JJ. Proceedings: Norepinephrine metabolism in subtypes of depressive disorders. Psychopharmacology Bulletin. 10: 49-50. PMID 4431872  1
1974 Roffman M, Riegle T, Orsulak P, Schildkraut JJ. Proceedings: Comparative properties of soluble and particulate catechol-O-methyl transferase from rat red blood cell: preliminary observations. Psychopharmacology Bulletin. 10: 43. PMID 4419340  1
1974 Roffman M, Reigle TG, Orsulak PJ, Schildkraut JJ. Comparative properties of soluble and particulate catechol-O-methyl transferases from rat red blood cells: preliminary observations. Advances in Biochemical Psychopharmacology. 12: 189-94. PMID 4417821  1
1974 Reigle TG, Avni J, Platz PA, Schildkraut JJ, Plotnikoff NP. Norepinephrine metabolism in the rat brain following acute and chronic administration of thyrotropin releasing hormone. Psychopharmacologia. 37: 1-6. PMID 4213267 DOI: 10.1007/BF00426676  1
1974 Schildkraut JJ. Catecholamine metabolism and affective disorders: Studies of MHPG excretion Biochemical Pharmacology. 23: 977-983. DOI: 10.1016/0006-2952(74)90172-5  1
1974 Reigle TG, Platz PA, Avni J, Schildkraut JJ. Influence of tranylcypromine isomers on the disposition and metabolism of norepinephrine H3 in rat brain Federation Proceedings. 33: No. 238.  1
1970 Greenspan K, Schildkraut JJ, Gordon EK, Baer L, Aronoff MS, Durell J. Catecholamine metabolism in affective disorders. 3. MHPG and other catecholamine metabolites in patients treated with lithium carbonate. Journal of Psychiatric Research. 7: 171-83. PMID 5440858  0.48
1969 Schildkraut JJ, Schanberg SM, Breese GR, Kopin IJ. Effects of psychoactive drugs on the metabolism of intracisternally administered serotonin in rat brain. Biochemical Pharmacology. 18: 1971-8. PMID 5811629  1
1969 Greenspan K, Schildkraut JJ, Gordon EK, Levy B, Durell J. Catecholamine metabolism in affective disorders. II. Norepinephrine, normetanephrine, epinephrine, metanephrine, and VMA excretion in hypomanic patients. Archives of General Psychiatry. 21: 710-6. PMID 4901154  0.48
1969 Schildkraut JJ, Schanberg SM, Kopin IJ, Durell J. Affective disorders and norepinephrine pharmacology. International Psychiatry Clinics. 6: 83-141. PMID 4897536  1
1968 Schanberg SM, Schildkraut JJ, KrÄ­vánek J, Kopin IJ. Effect of cortical spreading depression on norepinephrine-H3 metabolism in brain stem. Experientia. 24: 909-10. PMID 5709032 DOI: 10.1007/BF02138647  1
1968 Schanberg SM, Schildkraut JJ, Breese GR, Kopin IJ. Metabolism of normetanephrine-H3 in rat brain--identification of conjugated 3-methoxy-4-hydrophenylglycol as the major metabolite. Biochemical Pharmacology. 17: 247-54. PMID 5647052  1
1967 Schanberg SM, Schildkraut JJ, Kopin IJ. The effects of pentobarbital on the fate of intracisternally administered norepinephrine-H3. The Journal of Pharmacology and Experimental Therapeutics. 157: 311-8. PMID 6039823  1
1967 Schanberg SM, Schildkraut JJ, Kopin IJ. The effects of psychoactive drugs on norepinephrine-3-H metabolism in brain. Biochemical Pharmacology. 16: 393-9. PMID 6029920  1
1967 Schildkraut JJ, Kety SS. Biogenic amines and emotion. Science (New York, N.Y.). 156: 21-37. PMID 5335690  1
1967 Schildkraut JJ, Schanberg SM, Breese GR, Kopin IJ. Norepinephrine metabolism and drugs used in the affective disorders: a possible mechanism of action. The American Journal of Psychiatry. 124: 600-8. PMID 4383104  1
1966 Schildkraut JJ, Schanberg SM, Kopin IJ. The effects of lithium ion on H3-norepinephrine metabolism in brain. Life Sciences. 5: 1479-83. PMID 5969204  1
1966 Schildkraut JJ, Green R, Gordon EK, Durell J. Normetanephrine excretion and affective state in depressed patients treated with imipramine. The American Journal of Psychiatry. 123: 690-700. PMID 5333088  0.48
1965 Schildkraut JJ, Gordon EK, Durell J. Catecholamine metabolism in affective disorders. I. Normetanephrine and VMA excretion in depressed patients treated with imipramine. Journal of Psychiatric Research. 3: 213-28. PMID 5866611  0.48
Show low-probability matches.